{"id":"NCT01321541","sponsor":"CTI BioPharma","briefTitle":"Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant","officialTitle":"A Randomized Multicenter Study Comparing Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma Who Have Relapsed After Therapy With CHOP-R or an Equivalent Regimen and Are Ineligible for Stem Cell Transplant","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-04-20","primaryCompletion":"2018-06-28","completion":"2018-09-14","firstPosted":"2011-03-23","resultsPosted":"2021-11-19","lastUpdate":"2021-11-19"},"enrollment":312,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Diffuse Large B-cell Lymphoma","de Novo DLBCL","DLBCL Transformed From Indolent Lymphoma","Follicular Grade 3 Lymphoma"],"interventions":[{"type":"DRUG","name":"Pixantrone + Rituximab","otherNames":[]},{"type":"DRUG","name":"Gemcitabine + Rituximab","otherNames":[]}],"arms":[{"label":"Pixantrone + Rituximab","type":"EXPERIMENTAL"},{"label":"Gemcitabine + Rituximab","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy of Pixantrone + Rituximab compared to Gemcitabine + Rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), or follicular grade 3 lymphoma.","primaryOutcome":{"measure":"Progression Free Survival (PFS)","timeFrame":"From the date of randomization to the date of progressive disease or death due to any cause (whichever is first reported) (Up to 100 weeks)","effectByArm":[{"arm":"Pixantrone + Rituximab","deltaMin":7.3,"sd":null},{"arm":"Gemcitabine + Rituximab","deltaMin":6.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":131,"countries":["United States","Austria","Belgium","Bulgaria","Czechia","Denmark","France","Germany","Hungary","Italy","Poland","Romania","Russia","Slovakia","Spain","Ukraine","United Kingdom"]},"refs":{"pmids":["31879945","27093976"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":59,"n":153},"commonTop":["Neutropenia","Thrombocytopenia","Anaemia","Fatigue","Nausea"]}}